Erica Slaughter

Articles

Biofluid Biomarkers Hold Promise for the Future of Huntington Disease

April 29, 2019

Currently, there are no disease-modifying medications for Huntington disease and few interventions available to effectively alleviate symptoms, while the lack of indicators of pathobiological processes at the molecular level has limited the ability to prove efficacy and safety in clinical trials.